S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd

Deals & Filings

Page 2 of 4 · 60 articles on this desk

Deals & Filings coverage, page 2

Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

MicroVision clears its Nasdaq bid-price deficiency seven months on, after a 1-for-15 split and a $17m raise at $2.50

MicroVision said Monday that Nasdaq confirmed on August 26 that the company had regained compliance with the exchange's $1 minimum bid price rule and closed the matter. The cure followed a reverse split effective August 1 and a registered offering priced two weeks later that added 6.8m shares and an equal number of five-year warrants.

Adam Kowalczyk · August 31, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Cycurion's 1-for-8 Reverse Split Takes Effect Friday While Its Nasdaq Delisting Appeal Is Still Live

The consolidation cuts shares outstanding from about 25.8 million to about 3.2 million and is aimed at the exchange's minimum bid price rule. A separate Nasdaq standard the SEC approved in July measures market value, which a reverse split does not change.

Jonas Halvorsen · August 28, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

Greenland Mines Prices $20 Million Offering of 4 Million Shares Two Days After 1-for-50 Reverse Split

The 4 million shares being sold exceed the roughly 3.18 million shares the company said were outstanding after Monday's split. A separate Aug. 24 filing set up an at-the-market facility of up to $50 million on top of the offering.

Jonas Halvorsen · August 26, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Celularity Discloses Nasdaq Notice With Two 10-Qs Unfiled and a Sept. 4 Deadline to Submit a Compliance Plan

The company said Nasdaq wrote on Aug. 21 citing Listing Rule 5250(c)(1). Any exception the exchange grants would expire Nov. 16, and the most recent Celularity quarterly report on file, covering the first quarter of 2025, carries a going-concern warning.

Adam Kowalczyk · August 26, 2026
Illustrative photograph: computer server and electronics hardware.
Deals & Filings

Singularity Future Technology Priced Two Registered Directs Two Days Apart, Raising About $6.8 Million for a Data Center Business Its Last Annual Report Does Not Describe

The logistics company sold 2,162,500 shares at $3.00 and $3.20 in offerings announced Aug. 18 and Aug. 20. Its most recent quarterly filing shows $455,462 of six-month revenue against a $10.2 million net loss.

Jonas Halvorsen · August 25, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

Greenland Mines 1-for-50 Reverse Split Took Effect Monday, Cutting Shares to About 3.18 Million While Leaving the Authorized Count Untouched

The Nasdaq-listed exploration company's 1-for-50 consolidation became effective at 12:01 a.m. Eastern on Aug. 24, reducing roughly 158,850,637 shares outstanding to about 3,177,012, according to its Aug. 20 release. The board acted without a stockholder vote, fractional shares round up, and the number of authorized shares does not change. Neither the split release nor Friday's Greenland licence announcement disclosed a cash position or discussed how the company will fund its field programs.

Jonas Halvorsen · August 24, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

Jupiter Neurosciences Priced a $2.0 Million Registered Direct of 307,692 Shares Two Weeks After a 1-for-75 Reverse Split That Left About 770,081 Shares Outstanding

The Nasdaq-listed clinical-stage company said on Aug. 21 it had priced 307,692 shares for gross proceeds of approximately $2.0 million, with closing expected on or about Aug. 24. Its 1-for-75 reverse split took effect Aug. 6, cutting roughly 57,756,143 shares to about 770,081. A raise of the same $2.0 million in May required 7,142,858 pre-split shares — about 95,238 on a split-adjusted basis, roughly a third of the share count in the new deal.

Jonas Halvorsen · August 24, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

Smartkem's 1-for-50 Reverse Split Began Trading Friday. Behind it sit a going-concern warning, a $500 million equity line priced at a discount to the day's low, and board authority for a second consolidation.

Smartkem, Inc. (Nasdaq: SMTK) consolidated its common stock 1-for-50 after Thursday's close, saying the action was intended to satisfy the Nasdaq minimum bid price requirement. The company's most recent annual report disclosed $0.4 million of cash, a $125.1 million accumulated deficit and substantial doubt about its ability to continue as a going concern. Shareholders have authorised up to five billion shares and up to two reverse splits.

Jonas Halvorsen · August 21, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

K Wave Media Clears Nasdaq's Bid-Price Test and Prices a $1.0 Million Registered Direct the Same Day

Nasdaq determined that KWM's closing bid held at or above $1.00 for the ten sessions from August 4 through August 17, the window that followed a 1-for-30 reverse split. The same day the company priced 526,314 ordinary shares at $1.90 for roughly $1.0 million gross — about 20% of an implied post-split share count the desk derived, because the company has not published one. A separate $15 million market-value-of-publicly-held-shares deficiency stays open until December 14.

Jonas Halvorsen · August 19, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Ming Shing Failed Nasdaq's $2.5 Million Equity Test Six Days After Agreeing to a $510 Million All-Paper Acquisition

The Hong Kong contractor has until Oct. 1 to file a compliance plan. The 150 million Class A shares it agreed on Aug. 11 to issue are about 11.6 times its entire existing share count of 12,975,000.

Jonas Halvorsen · August 18, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Fast Track Group Called a 1-for-20 Consolidation Vote for Monday. Nasdaq Set the Stock's Suspension for Tuesday.

The delisting determination issued Aug. 11, six days before the meeting. A timely appeal stays the Form 25-NSE but, the company's own filing says, does not stay the suspension.

Adam Kowalczyk · August 18, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

T3 Defense Says It Regained Nasdaq Bid-Price Compliance After 1-for-125 Reverse Split

The micro-cap defense company told investors on August 17 that Nasdaq confirmed it back in compliance with the $1.00 minimum bid price rule, roughly a month after a steep reverse stock split cut its share count to about one million.

Adam Kowalczyk · August 18, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

MiniLuxe Announces a C$6 Million Dutch-Auction Buyback at C$0.40 to C$0.48, Above Monday's C$0.385 Close

The Boston-based nail-care operator said Tuesday morning that its board authorized a substantial issuer bid to repurchase for cancellation up to C$6,000,000 of its Class A subordinate voting shares through a modified Dutch auction priced at C$0.40 to C$0.48 a share — a range entirely above the C$0.385 close of Monday, August 17, the last completed session. The offer does not open until August 20 and runs to September 24. The August 18 release sets out the price range, the share math and the conditions; it does not state how the purchase would be funded, gives no cash balance and offers no rationale.

Adam Kowalczyk · August 18, 2026
Illustrative photograph: computer server and electronics hardware.
Deals & Filings

Gaxos.ai Closes $3.6 Million Warrant Repricing, Issuing Two New Warrants for Every Share Exercised

The nano-cap AI developer cut the strike on 3,007,654 outstanding warrants to $1.20 and handed holders 6,015,308 fresh warrants at $0.95 as the inducement. The transaction raises cash and enlarges the potential share count; it does not establish that the company has resolved the sub-$1.00 trading level that preceded the reverse-split authority put before shareholders at its August 11 annual meeting.

Adam Kowalczyk · August 18, 2026
Illustrative photograph: a modern corporate office interior.
Deals & Filings

AMASS Brands Issued Guidance Through 2027 That Its Own Release Says Does Not Assume the Capital It Still Needs to Raise

The beverage company, which reached Nasdaq by direct listing in May without raising capital, reported $5.6 million of second-quarter net revenue and $1.6 million of cash and cash equivalents on Monday. Its own risk list names past-due notes, substantial doubt about going concern, and dilution from a convertible preferred facility of up to $30 million.

Adam Kowalczyk · August 18, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Callan JMB Cleared Nasdaq's $1.00 Bid Price Without a Reverse Split. Its Other Listing Clock Runs to Oct. 4.

A letter dated Aug. 14 closed the bid-price file about six weeks after the notice arrived, and the company says the cure came from the closing bid price alone. A separate stockholders' equity deficiency disclosed in April has its own deadline.

Adam Kowalczyk · August 17, 2026
Illustrative photograph: people working in a business setting.
Deals & Filings

C3is Sets a 1-for-40 Reverse Split for Aug. 18, Its Third Since December 2024 — a Cumulative 1-for-2,000

Shares outstanding go from about 57.6 million to about 1.44 million. The Nasdaq-listed shipowner's Class B and Class C warrants keep adjusting for five trading days after the split takes effect.

Adam Kowalczyk · August 17, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Deals & Filings

Cycurion's Nasdaq Hearing Is Thursday. The Rule That Denied It a Cure Period Is Its Own 1-for-30 Split From Last October.

Cycurion, Inc. goes before a Nasdaq Hearings Panel on Aug. 20. Nasdaq determined the company is not eligible for the customary 180-day bid-price compliance period, and the company disclosed that determination in a July 16 release filed with the SEC. The provision cited, Listing Rule 5810(c)(3)(A)(iv), bars a compliance period for a company with a bid-price deficiency that has reverse split within the prior year — and Cycurion split 1-for-30 on Oct. 27, 2025.

Adam Kowalczyk · August 17, 2026